Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
出版年份 2018 全文链接
标题
Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 19, Issue 3, Pages 437-447
出版商
Springer Nature
发表日期
2018-01-28
DOI
10.1007/s40257-017-0341-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohnʼs Disease
- (2016) Marla C. Dubinsky et al. INFLAMMATORY BOWEL DISEASES
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
- (2015) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease
- (2014) Deirdre Nathalie Dufour et al. POSTGRADUATE MEDICAL JOURNAL
- Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- (2013) Alexa B. Kimball et al. ANNALS OF INTERNAL MEDICINE
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study
- (2012) C. Leonardi et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
- (2012) Paul Rutgeerts et al. GASTROENTEROLOGY
- Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States
- (2012) Irene Cosmatos et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis
- (2011) Craig Leonardi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease
- (2010) R. PANACCIONE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
- (2010) P. ETTEHADI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?
- (2009) L Matusiak et al. ACTA DERMATO-VENEREOLOGICA
- Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
- (2008) Jean E. Revuz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now